Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93383 | 0.92 | — | — | |
| Benzene SCHEMBL8045689 | 0.86 | TDP1 (0.41) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL475462 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL9679147 | 0.85 | TSHR (0.38) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL17358693 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL19410608 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL1094765 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL19410575 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL1095965 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 | |
| SCHEMBL19410597 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530559-B2 | Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites | DIC CORPORATION (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | DIC CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | AOC3, AOC2, CORO1C | ALDH1A1 924/4885SMN1; SMN2 1080/4885TDP1 4011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.